NCM Capital Management Group’s Pfizer PFE Stock Holding History

NCM Capital Management Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$95K	Hold	2,951	–	–	1.15%	34
2016 Q2	$99K	Sell	2,951 -106	-3%	-$3.38K	1.21%	35
2016 Q1	$86K	Sell	3,057 -105	-3%	-$3K	1.05%	40
2015 Q4	$97K	Hold	3,162	–	–	1.14%	36
2015 Q3	$94K	Hold	3,162	–	–	1.17%	37
2015 Q2	$101K	Hold	3,162	–	–	1.14%	42
2015 Q1	$104K	Hold	3,162	–	–	1.18%	38
2014 Q4	$93K	Buy	3,162 +53	+2%	+$1.52K	1.05%	39
2014 Q3	$87K	Sell	3,109 -53	-2%	-$1.49K	1.02%	43
2014 Q2	$89K	Sell	3,162 -369	-10%	-$10.5K	1.04%	43
2014 Q1	$108K	Hold	3,531	–	–	0.85%	48
2013 Q4	$103K	Hold	3,531	–	–	0.07%	101
2013 Q3	$96K	Sell	3,531 -105	-3%	-$2.86K	0.07%	97
2013 Q2	$97K	Buy	+3,636	New	+$100K	0.07%	95

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

NCM Capital Management Group's PFE Position: Q3 2016 in Review

NCM Capital Management Group held its Pfizer (PFE) position steady in Q3 2016 at 2,951 shares worth $95K. The position accounts for 1.15% of the portfolio, ranked #34.

NCM Capital Management Group first reported a position in PFE in Q2 2013 and has held it in 14 quarters since. The position peaked at $108K in Q1 2014. 1,962 funds tracked by Wall St. Rank hold PFE as of Q3 2016.

NCM Capital Management Group held 2,951 shares of Pfizer worth $95K as of Q3 2016.
NCM Capital Management Group left its Pfizer share count unchanged in Q3 2016.
Pfizer made up 1.15% of NCM Capital Management Group's portfolio in Q3 2016, its #34 holding.
NCM Capital Management Group first reported a position in Pfizer in Q2 2013 and has held it in 14 quarters since.
NCM Capital Management Group's Pfizer position peaked at $108K in Q1 2014.
1,962 funds tracked by Wall St. Rank held Pfizer as of Q3 2016.

Based on NCM Capital Management Group's 13F filing for Q3 2016, filed 7 Nov 2016.